Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-19

Clinical Trial Update: Efficacy Study & Safety Evaluation of SR-T100 Gel in Actinic Keratosis Treatment [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 efficacy and safety evaluation of SR-T100 Gel for actinic keratosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SR-T100 Gel

Snippet

Sponsor: G&E Herbal Biotechnology Co., LTD | Conditions: Actinic Keratosis | Phase 3 | Status: COMPLETED